Filing Flows › Lantheus Holdings (LNTH) › Neuraceq revenue
Lantheus Holdings (LNTH) Neuraceq revenue by quarter
Lantheus Holdings' Neuraceq revenue was $45.6M in Q3 2026 (third quarter 2026), +15% from Q2 2026. Over the last 5 quarters it ranged from $20.4M (Q3 2025) to $45.6M (Q3 2026).
| Quarter | Neuraceq revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $45.6M | +15% | +123% |
| Q2 2026 | $39.6M | +12% | — |
| Q1 2026 | $35.4M | +14% | — |
| Q4 2025 | $31.0M | +52% | — |
| Q3 2025 | $20.4M | — | — |
Q3 2026 at a glance
Lantheus Holdings, Q3 2026: revenue $390M (+2% year over year), operating margin 8.3%, net earnings $22.4M, operating cash flow $102M. The chart follows the revenue to costs, profit and cash.
Questions
What is Lantheus Holdings' Neuraceq revenue?
Lantheus Holdings' Neuraceq revenue was $45.6M in Q3 2026 (third quarter 2026), +15% from Q2 2026.
How has Lantheus Holdings' Neuraceq revenue changed?
Over the last 5 quarters it ranged from $20.4M (Q3 2025) to $45.6M (Q3 2026).